English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Orsini Healthcare
Press release submission
| Jul 12, 2020
ORSINI PHARMACEUTICAL: Services Expands Partnership With Ultragenyx To Provide Dojolvi™ (triheptanoin) - For Patients With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)
Trending
+
Pharmaceuticals
Patient Daily
| Jun 10, 2025
Radiation oncologist on 340B program: ‘It is used as a consolidation tool by large institutions to kill competition in the market’
+
Pharmaceuticals
Patient Daily
| Jun 4, 2025
Doctor on compounded medications: They 'meet individual patient needs when commercial drugs are unsuitable'
+
Pharmaceuticals
Patient Daily
| Jun 9, 2025
Director of Public Affairs of PhRMA: ‘There is also evidence that 340B is harming state and federal budgets’
+
Pharmaceuticals
Patient Daily
| Jun 5, 2025
Exon 20 Group questions effectiveness of 340B drug program
